Live GENSCRIPT price
GENSCRIPT price chart
GENSCRIPT (GENSCRIPT) price details
GENSCRIPT price history
GENSCRIPT technical analysis

GENSCRIPT (GENSCRIPT) sentiment
About GENSCRIPT
GenScript Biotech is a world-leading life science research and application service provider specializing in gene synthesis technology. The company offers a wide range of services spanning life science research tools, industrial synthetic biology products, and cell therapy development. GenScript is highly regarded for its role in enabling breakthrough innovations in biotechnology, pharmacology, and agriculture.
Official links
Social media and community
FAQ
1. What is the current price of GENSCRIPT (GENSCRIPT) in USD?
2. What is the market capitalization of GENSCRIPT (GENSCRIPT)?
3. What is the circulating supply of GENSCRIPT (GENSCRIPT)?
4. What factors influence the price of GENSCRIPT (GENSCRIPT)?
5. Is GENSCRIPT (GENSCRIPT) a good investment?
6. Where can I buy GENSCRIPT (GENSCRIPT)?
7. What are the typical fees when buying GENSCRIPT (GENSCRIPT)?
8. What are some technical indicators used for analyzing GENSCRIPT (GENSCRIPT)?
Currency price converter
Popular
How to buy
GENSCRIPT news
BCG Study Puts Custody At The Center Of Banks’ Digital Asset Plans
Firedancer makes bounty hunters burn 1 SOL even for duplicate bug reports
Firedancer requires a non-refundable 1 SOL burn for bug-bounty eligibility, even for duplicates. Later reports can still earn discretionary rewards.
Interpol: 1,462 Arrests and Crypto Money Laundering Networks Dismantled in Africa
NYSE’s owner is backing 24/7 stock tokens without Wall Street’s usual price rules
NYSE owner ICE backs OKXICE's 24/7 stock token plans as 16 issuers object and automated liquidity pools raise pricing issues.
Bitcoin Hashrate Reclaims One Zettahash As Mining Competition Rebounds
Will Anthropic Delay Its 'Super IPO' Amid AI Trading Collapse? The Scheduled Listing Date in Mid-November Approaches
The time window is extremely tight—according to SEC regulations, the S-1 filing must be submitted by next week at the latest, with market predictions giving an 80% chance of an IPO this year. The AI sector's sell-off casts a shadow over the IPO prospects, as a previous plan for a September listing h...












